Related Experiment Videos
Central nervous system involvement in Wegener granulomatosis
Raphaèle Seror1, Alfred Mahr, Jacky Ramanoelina
1From Department of Internal Medicine, Hôpital Cochin, Université René-Descartes Paris 5, Assistance Publique-Hôpitaux de Paris, Paris, France.
Medicine
|March 9, 2006
Summary
Wegener granulomatosis (WG), an ANCA-associated vasculitis, can affect the central nervous system (CNS). This study details 6 WG patients with CNS involvement, highlighting varied presentations and management strategies.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Wegener granulomatosis (WG), now known as granulomatosis with polyangiitis (GPA), is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
- It typically affects small to medium-sized vessels, primarily impacting the respiratory tract and kidneys, but can involve any organ system.
- Central nervous system (CNS) involvement is a rare but serious complication of WG/GPA, occurring in 7%-11% of patients.
Observation:
- This study presents 6 patients with WG/GPA-related CNS involvement.
- Presentations included chronic hypertrophic pachymeningitis (2 patients), pituitary involvement (3 patients), and cerebral vasculitis (1 patient).
- CNS involvement was the initial manifestation in 2 patients and occurred years after WG/GPA diagnosis in the remaining 4.
Findings:
- WG/GPA can manifest in the CNS through contiguous granuloma invasion, remote intracranial granulomas, or CNS vasculitis.
- Clinical features, imaging findings, and treatment outcomes for meningeal, pituitary, and vascular CNS involvement were analyzed.
- Differential diagnoses, prognosis, and therapeutic strategies for WG/GPA-related CNS disease were discussed.
Implications:
- Understanding the diverse CNS manifestations of WG/GPA is crucial for timely diagnosis and effective management.
- Early recognition and appropriate treatment can improve outcomes for patients with WG/GPA affecting the CNS.
- This review provides valuable insights for clinicians managing complex cases of WG/GPA with neurological involvement.